Dj. Morgan et al., INFLUENCE OF ALBUMIN ON ISOPRENALINE AND PROPRANOLOL EFFECTS ON ISOLATED RAT UTERUS, Biopharmaceutics & drug disposition, 14(7), 1993, pp. 627-633
We investigated the effect of albumin (6%) on the (+/-)-isoprenaline-i
nduced relaxation of strips of isolated rat uterus and its antagonism
by (-)-propranolol. The mean isoprenaline EC50 in the presence of albu
min was significantly less than that in the absence of albumin (geomet
ric mean 1.94 +/- 3.33 versus 3.21 +/- 3.50 nM, respectively; n = 14;
p = 0.006, paired t test). This indicates enhancement of isoprenaline
activity by albumin which could not be explained by protein binding, a
s this would have reduced activity. Geometric mean control K(B) values
for inhibition of isoprenaline by propranolol at 26.8 and 500 nM were
0.835 +/- 1.68 (n = 10) and 0.889 +/- 1.60 nM (n = 34), respectively.
In the presence of 6% albumin, K(B) for propranolol was increased sig
nificantly to 13.3 +/- 1.8 nM (n = 27, p < 0.001). Calculation of K(B)
in terms of the measured propranolol unbound concentration of 26.8 nM
, after taking into account the lower isoprenaline EC50 in the presenc
e of albumin, yielded a mean value of 0.725 +/- 1.86 nM, which was not
significantly different from either control (p > 0.05). Therefore, pr
opranolol activity was as predicted by the unbound drug concentration
in contrast to isoprenaline activity. We conclude that albumin can alt
er in vitro drug activity by mechanisms in addition to the reduction o
f unbound drug concentration.